- This event has passed.
SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
October 15, 2019 - October 16, 2019
SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK.
The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.
This is due to the arising interest for pharmaceutical companies, primarily for the underlying benefits, including the potential discovery of mechanisms for more common diseases, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases.
The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
BENEFITS OF ATTENDING
- HEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs
- DISCUSS the potential changes in assessing the development of medicines across Europe
- EXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.
PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
Thursday 17th October 2019
A deep dive into strategies for accelerating patient access of orphan drugs
Workshop Leader: Workshop Leaders: Solange Corriol-Rohou, Senior Director Regulatory Affairs & Policy Europe, AstraZeneca
Cecile Ollivier, Chief Operating Officer, Aparito
WHO SHOULD ATTEND?
CEOs, CSOs, Vice Presidents, Directors, Heads, Principals working in:
- Medical Affairs
- Medical Advisory
- Clinical Operations
- Rare Disease Research
- Patient Advocacy
- Commercial Officer
- Orphan Drug Therapeutics
- Healthcare
- Regulatory Affairs
- Rare Disease Charity Officers
For more details and to register or this event, visit the website at http://www.orphandrugs.co.uk/PJWL
EARLY BIRD-RATES
- BOOK BY 31ST MAY AND SAVE £400
- BOOK BY 28TH JUNE AND SAVE £300
- BOOK BY 30TH AUGUST AND SAVE £200